 Shares of CTI BioPharma Corp NASDAQ:CTIC gapped up prior to trading on Wednesday after Needham Company LLC raised their price target on the stock from 3.50 to 6.00. The stock had previously closed at 1.05, but opened at 2.53. Needham Company LLC currently has a buy rating on the stock. CTI BioPharma shares ... 